/GCTK
GCTK Stock - GlucoTrack, Inc.
Healthcare|Medical - Instruments & SuppliesNASDAQ
$4.74+1.28%
+$0.06 (+1.28%) • Dec 19
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $5.21
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for GCTK
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$4.69 – $4.79
TARGET (TP)$5.45
STOP LOSS$4.36
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.30
52W High$468.00
52W Low$4.22
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | $-36,000 | $-13,000 | $-23,000 | N/A | $-47,000 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-14,547,000 | $-7,104,000 | $-4,432,000 | $-4,040,000 | $-3,132,000 |
| Net Income | $-22,597,000 | $-7,097,000 | $-4,435,000 | $-4,067,000 | $-2,696,000 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $60.76 | $-38.30 | $-28.66 | $-26.32 | $-17.88 |
Company Overview
GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
GCTKBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-4.64
Q4 2025
EPS Surprise History
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 13, 2025 | — | $-4.64 | — | — |
Q3 2025 | Aug 14, 2025 | — | $-9.62 | — | — |
Q2 2025 | May 14, 2025 | — | $-20.36 | — | — |
Q1 2025 | Mar 27, 2025 | — | $10.00 | — | — |
Q4 2024 | Nov 14, 2024 | — | $-1089.82 | — | — |
Q3 2024 | Aug 13, 2024 | — | $-982.04 | — | — |
Q2 2024 | May 15, 2024 | — | $-718.56 | — | — |
Q1 2024 | Mar 28, 2024 | — | $-598.80 | — | — |
Q4 2023 | Nov 14, 2023 | — | $-0.10 | — | — |
Q3 2023 | Aug 14, 2023 | — | $-5.45 | — | — |
Q2 2023 | May 12, 2023 | — | $-8.31 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-8.29 | — | — |
Q4 2022 | Nov 14, 2022 | — | $-5.99 | — | — |
Q3 2022 | Aug 15, 2022 | — | $-7.31 | — | — |
Q2 2022 | May 16, 2022 | — | $-7.07 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-9.74 | — | — |
Q4 2021 | Nov 15, 2021 | — | $-5.20 | — | — |
Q3 2021 | Aug 16, 2021 | — | $-5.52 | — | — |
Q2 2021 | May 21, 2021 | — | $-5.85 | — | — |
Q2 2021 | Apr 30, 2021 | — | $-5.68 | — | — |
Latest News
GlucoTrack Q3 EPS $(4.64) Up From $(1.09 thousand) YoY
📈 PositiveBenzinga•Nov 13, 2025, 09:31 PM
GlucoTrack Has Been Granted U.S. Patent Number 12,453,494 Titled "Methods And Systems For Measuring Glucose Having Improved Decay Rates And Lag Times"
📈 PositiveBenzinga•Oct 28, 2025, 07:58 PM
Reported September 12, 2025: Glucotrack, Issues $3.6M Unsecured Convertible Promissory Note To Investor For A Purchase Price Of $3M
➖ NeutralBenzinga•Sep 15, 2025, 04:03 PM
GlucoTrack Shares Halted On Circuit Breaker To The Upside, Stock Now Up 146.61%
📈 PositiveBenzinga•Sep 12, 2025, 04:15 PM
GlucoTrack shares are trading higher after the company announced it entered into a purchase agreement with Sixth Borough Capital. Sixth Borough Capital committed to purchase up to $20 million of the company's stock.
📈 PositiveBenzinga•Sep 12, 2025, 12:32 PM
Market-Moving News for September 12th
➖ NeutralBenzinga•Sep 12, 2025, 11:23 AM•Also: ,
GlucoTrack Enters Purchase Agreement With Sixth Borough Capital; Sixth Borough Capital Fund Commits To Purchase Up To $20M Of Co's Common Stock
📈 PositiveBenzinga•Sep 11, 2025, 09:00 PM
Glucotrack announces 1-for-60 reverse stock split
📉 NegativeSeeking Alpha•Jun 12, 2025, 01:26 PM
Frequently Asked Questions about GCTK
What is GCTK's current stock price?
GlucoTrack, Inc. (GCTK) is currently trading at $4.74 per share. The stock has moved +1.28% today.
What is the analyst price target for GCTK?
No analyst price targets are currently available for this stock.
What sector is GlucoTrack, Inc. in?
GlucoTrack, Inc. operates in the Healthcare sector, specifically within the Medical - Instruments & Supplies industry. The company is traded on the NASDAQ exchange.
What is GCTK's market cap?
GlucoTrack, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does GCTK pay dividends?
No, GlucoTrack, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAKAN
Akanda Corp.
$0.61
Mkt Cap: $0.0B
BBLG
Bone Biologics Corporation
$1.83
Mkt Cap: $0.0B
BGMS
Bio Green Med Solution, Inc.
$1.39
Mkt Cap: $0.0B
DHAI
DIH Holding US, Inc.
$0.00
Mkt Cap: $0.0B
HSCS
HeartSciences Inc.
$2.36
Mkt Cap: $0.0B
INM
InMed Pharmaceuticals Inc.
$1.19
Mkt Cap: $0.0B
NAOV
NanoVibronix, Inc.
$4.02
Mkt Cap: $0.0B
NDRA
ENDRA Life Sciences Inc.
$5.16
Mkt Cap: $0.0B
RDHL
RedHill Biopharma Ltd.
$1.18
Mkt Cap: $0.0B
VERO
Venus Concept Inc.
$1.92
Mkt Cap: $0.0B
Explore stocks similar to GCTK for comparison